Eli Lilly is suing four telemedicine companies selling compounded versions of its blockbuster obesity drug Zepbound and its ...

While much of the conversation around the Trump administration’s potential pharmaceutical import tariffs has leaned heavily ...

The FAA's new Center for Advanced Aviation Technologies (CAAT) will be managed by the Texas A&M University System (TAMUS), ...

Eli Lilly is suing four telehealth companies that prescribe compounded versions of the pharmaceutical company's weight loss ...

Durbin, top Democrat on the Senate's Judiciary Committee from 2021 until this year, led the 2022 confirmation of Supreme ...

The president of Omada Health talks about why decision makers need to be thinking about holistic weight-management care as ...

A growing number of pharmaceutical companies are sharing plans to ramp up domestic manufacturing capacity amid recent tariffs imposed by the Trump administration. Here are five things to know: ...

In its continuing war against copycat drugs, Eli Lilly (LLY) said on Wednesday that it filed suits against four telehealth ...

Eli Lilly has unleashed another wave of litigation against four telehealth brands in its widening legal war with sellers of alternative versions of its popular diabetes and weight-loss drugs.

During a conversation with senior writer @EdEastonJr, Philadelphia Eagles legend Brian Dawkins reflects on the Rose Parade and Brandon Graham's career ...

U.S. Treasury Secretary Scott Bessent said on Wednesday that he believes that excessively high tariffs between the U.S. and ...

Eli Lilly ( LLY 0.89%) has been growing its sales at a good clip over the past year. This is partly thanks to Zepbound, a ...